Wambabya-Rwamarongo onchocerciasis focus is one of the eight foci Uganda verified using the WHO verification guidelines. The approach for elimination was twice yearly treatment with ivermectin for every round, treating at least 90% of all the eligible population. This was in combination with vector elimination using Abate (BASF SE, Limburgerhof, Germany) since elimination nationwide policy was launched.
View Article and Find Full Text PDF